James B. Hermiller, MD, FACC, FSCAI

Feature

DRUG-ELUTING STENT SOLUTIONS: DELIVERABILITY IN DES

06/19/2008

Dr. Hermiller received his undergraduate degree from Miami University in Oxford, Ohio, and earned his MD from Ohio State University School of Medicine in Columbus, Ohio. He did his internship and residency in internal medicine at the...

Dr. Hermiller received his...

06/19/2008

Cath Lab Digest

Original Contribution

Efficacy of a Novel Procedure Sheath and Closure Device during
Diagnostic Catheterization: The Multicenter Randomized Clinical

08/01/2008

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

Anthony A. Bravry , MD, MPH;

Russell E. Raymond , DO;

Charles E. Chambers , MD;

Andrew J. DeNardo , MD;

James B. Hermiller , MD, FACC, FSCAI;

Paul R. Myers , MD;

Douglas E. Pitts , MD;

John A. Scott , MD;

Scott J. Savader , MD;

Steven R. Steinhubl , MD;

Multiple devices are currently available for closure of the femoral artery access site after cardiac catheterization.1 Currently, the most widely used closure devices are the Angio-Seal™ device (St. Jude Medical, St. Paul, Minnesota)2–4 and...

Multiple devices are currently...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Clinical Experience with a Circumferential Clip-Based Vascular Closure Device in Diagnostic Catheterization

08/01/2008

Carol Anne Yarbrough , RN;

Michael Zapien ;

Charles A. Simonton III, MD;

Louis Cannon , MD, FACC, FACP;

Daniel T. Lee , MD;

Michael R. Mooney , MD;

James B. Hermiller , MD, FACC, FSCAI;

Tony M. Chou , MD;

Tomoaki Hinohara , MD;

Harold Carlson , MD;

Charles O'Shaughnessy , MD;

Richard Fortuna , MD, PhD;

Approximately 7 million angiograms and interventional procedures are performed worldwide each year, and the incidence of these procedures continues to rise, particularly in developing countries. The vast majority of these procedures are...

Approximately 7 million...

08/01/2008

Journal of Invasive Cardiology

Calcium Corner

ABSORB III and IV: Evaluating the Safety and Effectiveness of the Absorb Bioresorbable Vascular Scaffold

01/13/2015

James B. Hermiller , MD, FACC, FSCAI;

With the Absorb BVS, by a year, there is a loss of some of the radial strength. By two years, we start to see loss of the scaffold itself, meaning the mass and structure of the device, and by three to three and a half years, the BVS is gone.

With the Absorb BVS, by a year,...

01/13/2015

Cath Lab Digest

DRUG-ELUTING STENT SOLUTIONS: DELIVERABILITY IN DES

06/19/2008

James B. Hermiller , MD, FACC, FSCAI;

Dr. Hermiller received his...

06/19/2008

Cath Lab Digest

Review

Bifurcation Coronary Artery Disease: Current Techniques and
Future Directions (Part 1)

08/01/2008

Kevin J. Klassen , MD;

James B. Hermiller , MD, FACC, FSCAI;

David G. Rizik , MD, FACC, FSCAI;

Published randomized trials of drug-eluting stents (DES) have shown reduced rates of restenosis and target lesion revascularization (TLR) in noncomplex lesions compared to bare-metal stents (BMS).1 Given this documented success of the...

Published randomized trials of...

08/01/2008

Journal of Invasive Cardiology

Commentary

COMMENTARY: Bifurcations: The Problem is the Side Branch

08/01/2008

Ali Rizvi , MD;

James B. Hermiller , MD, FACC, FSCAI;

Bifurcation disease continues to be one of the complex coronary lesion subsets that remains a challenge. The percutaneous treatment of bifurcations is common, accounting for up to 20% of interventions, and the frequency has increased in the...

Bifurcation disease continues to...

08/01/2008

Journal of Invasive Cardiology

Review

Bifurcation Coronary Artery Disease: Current Techniques and
Future Directions (Part 2)

08/01/2008

David G. Rizik , MD, FACC, FSCAI;

Kevin J. Klassen , MD;

James B. Hermiller , MD, FACC, FSCAI;

Overview of Dedicated Bifurcation Devices. Recent angiographic2 and intravascular ultrasound (IVUS)10 studies have convincingly demonstrated that the success of bifurcation treatment in reducing major adverse cardiac events (MACE) is...

Overview of Dedicated...

08/01/2008

Journal of Invasive Cardiology

Commentary

Bifurcation Intervention: Keep it Simple

08/01/2008

James B. Hermiller , MD, FACC, FSCAI;

The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...

The percutaneous treatment of...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients

02/24/2015

Nick Cavros , MD;

Nilesh J. Goswami , MD;

Wayne Leimbach , MD;

Roger Gammon , MD;

Steven P. Karas , MD;

John McCabe , MD;

Richard Paulus , MD;

James B. Hermiller , MD, FACC, FSCAI;

Zoltan G. Turi , MD;

Shing-Chiu Wong , MD;

Srihari S. Naidu , MD;

Robert J. Whitbourn , MD, MBBS;

The RESPECT trial was a multicenter, randomized comparison that evaluates the safety/efficacy of the new Vascade extravascular closure system (Cardiva Medical, Inc) in diagnostic and interventional procedures. Compared to manual compression,...

The RESPECT trial was a...

02/24/2015

Journal of Invasive Cardiology